Nothing Special   »   [go: up one dir, main page]

DE69933699D1 - Verfahren zur produktion rekombinanter proteine in säugetierzellen durch co-expression mit fetuin - Google Patents

Verfahren zur produktion rekombinanter proteine in säugetierzellen durch co-expression mit fetuin

Info

Publication number
DE69933699D1
DE69933699D1 DE69933699T DE69933699T DE69933699D1 DE 69933699 D1 DE69933699 D1 DE 69933699D1 DE 69933699 T DE69933699 T DE 69933699T DE 69933699 T DE69933699 T DE 69933699T DE 69933699 D1 DE69933699 D1 DE 69933699D1
Authority
DE
Germany
Prior art keywords
fetuin
expression
production
mammalian cells
recombinant proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69933699T
Other languages
English (en)
Other versions
DE69933699T2 (de
Inventor
Yuen Chan
Van-Mai Tran
Shu-Lan Cheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp filed Critical Bayer Corp
Application granted granted Critical
Publication of DE69933699D1 publication Critical patent/DE69933699D1/de
Publication of DE69933699T2 publication Critical patent/DE69933699T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69933699T 1998-07-28 1999-07-08 Verfahren zur produktion rekombinanter proteine in säugetierzellen durch co-expression mit fetuin Expired - Lifetime DE69933699T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/124,605 US6051401A (en) 1998-07-28 1998-07-28 Methods and constructs for protein expression
US124605 1998-07-28
PCT/US1999/015367 WO2000006713A2 (en) 1998-07-28 1999-07-08 Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin

Publications (2)

Publication Number Publication Date
DE69933699D1 true DE69933699D1 (de) 2006-11-30
DE69933699T2 DE69933699T2 (de) 2007-08-23

Family

ID=22415830

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69933699T Expired - Lifetime DE69933699T2 (de) 1998-07-28 1999-07-08 Verfahren zur produktion rekombinanter proteine in säugetierzellen durch co-expression mit fetuin

Country Status (10)

Country Link
US (1) US6051401A (de)
EP (1) EP1144611B1 (de)
JP (1) JP3861134B2 (de)
AR (1) AR022058A1 (de)
AU (1) AU4974299A (de)
CA (1) CA2337088C (de)
DE (1) DE69933699T2 (de)
ES (1) ES2275346T3 (de)
TW (1) TWI245048B (de)
WO (1) WO2000006713A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
US7238662B2 (en) * 1997-12-18 2007-07-03 Ambryx Biotechnology, Inc. Alpha 2HS glycoprotein for treatment of cancer and a method for preparation thereof
US7186555B1 (en) * 1999-04-13 2007-03-06 The Feinstein Institute For Medical Research Prevention of brain damage in stroke
US20030044400A1 (en) * 2001-05-22 2003-03-06 Jenny Yu Composition and method for treating cells
JP2007528862A (ja) * 2003-07-16 2007-10-18 アールブイエックス セラピューティクス， インコーポレイテッド ＴＧＦ−βの効果を下方制御するための化合物および方法
EP2320933B1 (de) 2008-07-17 2017-12-27 Acorda Therapeutics, Inc. Therapeutische dosierung eines neuregulins oder einer subsequenz davon zur behandlung oder prophylaxe von herzversagen
ES2827923T3 (es) 2008-08-15 2021-05-25 Acorda Therapeutics Inc Composiciones y métodos de tratamiento durante los períodos no agudos después de una lesión neurológica del CNS
JP6542678B2 (ja) 2013-03-06 2019-07-10 アコーダ セラピューティクス インコーポレイテッド 心不全の治療または予防のためのニューレグリンまたはその断片の治療的投与の方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57194787A (en) * 1981-05-28 1982-11-30 Ajinomoto Co Inc Culture medium for animal cell
US4560655A (en) * 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4767704A (en) * 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
US4757005A (en) * 1984-04-19 1988-07-12 Miles Inc. Method and cell line for obtaining plasminogen activators
US4816401A (en) * 1985-09-09 1989-03-28 University Of Rochester Serum free cell culture medium
DK175363B1 (da) * 1986-09-12 2004-09-13 Genentech Inc Fremgangsmåde til kontinuert produktion af et önsket heterologt protein i en eukaryotisk værtcelle, vektor, som tilförer denne evne, og celler transformeret med vektoren
US5024947A (en) * 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
US5081035A (en) * 1988-04-18 1992-01-14 The University Of Michigan Bioreactor system
US5153131A (en) * 1990-12-11 1992-10-06 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration High aspect reactor vessel and method of use
US5143842A (en) * 1988-11-01 1992-09-01 The University Of Colorado Foundation, Inc. Media for normal human muscle satellite cells
US5135866A (en) * 1989-03-03 1992-08-04 W. R. Grace & Co.-Conn. Very low protein nutrient medium for cell culture
US5122469A (en) * 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
JPH04228066A (ja) * 1990-10-23 1992-08-18 Rikagaku Kenkyusho 外来遺伝子発現用培養細胞
US5530109A (en) * 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
EP0874057B1 (de) * 1993-06-10 2004-07-28 Bayer Corporation Vektoren und Zelllinien von Säugetieren mit erhöhter Produktivität
US5631159A (en) * 1993-09-22 1997-05-20 Creative Biomolecules, Inc. Lipid-modified serum free media
EP0891419A4 (de) * 1996-03-12 2000-03-01 Life Technologies Inc Nährstoffzusatz für hematopoetische zellkulturen
US5854021A (en) * 1997-02-28 1998-12-29 Bayer Corporation Enhance protein production method

Also Published As

Publication number Publication date
WO2000006713A8 (en) 2001-11-08
JP3861134B2 (ja) 2006-12-20
EP1144611A3 (de) 2001-11-28
WO2000006713A2 (en) 2000-02-10
EP1144611A2 (de) 2001-10-17
CA2337088A1 (en) 2000-02-10
DE69933699T2 (de) 2007-08-23
AR022058A1 (es) 2002-09-04
US6051401A (en) 2000-04-18
WO2000006713A3 (en) 2001-08-09
CA2337088C (en) 2005-01-11
JP2002524033A (ja) 2002-08-06
EP1144611B1 (de) 2006-10-18
AU4974299A (en) 2000-02-21
ES2275346T3 (es) 2007-06-01
TWI245048B (en) 2005-12-11

Similar Documents

Publication Publication Date Title
DE69637867D1 (de) Verfahren zur Kontrollierung der Sialylierung von durch Säugetierzellkultur hergestellten Proteinen
DE59608743D1 (de) Verfahren zur herstellung von rekombinanten proteinen in e. coli mittels hochzelldichte-fermentation
DE69840678D1 (de) Verfahren zur produktion von purinnukleosiden durch fermentation
ATE405644T1 (de) Verfahren zur herstellung und reinigung von erythropoietin
DE502004008542D1 (de) Verfahren zur reklonierung von produktionszellen
PL377731A1 (pl) Sposoby hodowli komórek ssaczych do wytwarzania białka
DE69842174D1 (de) Verfahren zur Herstellung humanisierter Antikörper durch randomisierte Mutagenese
AU2002356749A1 (en) Process for the production of polypeptides in mammalian cell cultures
DK1220934T3 (da) Fremgangsmåde til fremstilling af rekombinante proteiner med anvendelse af apoptoseinhibitorer
DE3851289D1 (de) Verfahren zur Züchtung rekombinanter Zellen.
AR020735A1 (es) Un procedimiento para la obtencion de un polipeptido glucosilado a partir de celulas eucarioticas
ATE278024T1 (de) Methode zur herstellung von rekombinanten zellen
DE69632887D1 (de) Verfahren zur zweckmässige Herstellung von Transglutaminase durch DNA-Rekombination
DE69939548D1 (de) Verfahren zur herstellung von faktor vii
DE69933699D1 (de) Verfahren zur produktion rekombinanter proteine in säugetierzellen durch co-expression mit fetuin
DE60106469D1 (de) Verfahren zur Herstellung von genetisch veränderten Lymphozyten Vorläuferzellen von Wirbeltieren und deren Gebrauch zur Produktion von heterologen Bindeproteinen
DE59402821D1 (de) Verfahren zur Herstellung flächiger kaschierter Teile unter Verwendung von Gitterförmigen Vorformlingen
DK0658626T3 (da) Fremgangsmåder til produktion af protein C
WO2002016584A3 (en) Process for the preparation of neutrophil inhibitory factor
ATE318919T1 (de) Verfahren zur herstellung von proteinen in transformierten hefezellen
DE60037181D1 (de) Verfahren zur herstellung von polypeptiden in cyclohexadepsipeptid-defizienten zellen
ATE288476T1 (de) Herstellung von proteinen
TNSN01128A1 (en) Process for the preparation of a neutrophil inhibitory factor
DE69834900D1 (de) Verfahren zur Herstellung von Zellkulturen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition